Gilead Sciences GILD
NASDAQ GILD
$170.87 +1.55 (+0.92%)
At close: Nov 10, 2026 · 4:00 PM EST

Gilead Sciences (GILD) Share-based Compensation (IS) (2009 - 2011)

Updated

Analysis

Gilead Sciences (GILD) Share-based Compensation (IS) (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 35.22 Mn
Jun 30, 2011 37.92 Mn
Mar 31, 2011 36.61 Mn
Sep 30, 2010 37.81 Mn
Jun 30, 2010 34.40 Mn
Mar 31, 2010 34.41 Mn
Sep 30, 2009 36.22 Mn
Jun 30, 2009 39.96 Mn
Mar 31, 2009 30.29 Mn
API Access

Gilead Sciences Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=GILD&period=max&api_key=YOUR_API_KEY